ClinicalTrials.Veeva
Menu

Find clinical trials for Lung Cancer in San Antonio, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma
Cancer
Small Cell Lung Carcinoma
Colorectal Cancer
Squamous Cell Carcinoma of Head and Neck
Breast Cancer
Carcinoma

Lung Cancer trials near San Antonio, TX, USA:

A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer

given with chemotherapy to adults with extensive-stage small cell lung cancer (ES-SCLC), a fast-growing type of lung cancer...

Enrolling
Small Cell Lung Cancer (SCLC)
Drug: Chemotherapy
Drug: PF-08634404

Phase 2, Phase 3

Pfizer
Pfizer

San Antonio, Texas, United States and 5 other locations

combination) vs durvalumab in limited-stage (LS)-small-cell lung cancer (SCLC) participants.The main goals of this study are to:* E...

Enrolling
Limited Stage Small Cell Lung Cancer
Drug: Durvalumab
Drug: BMS-986489

Phase 2

SCRI Development Innovations

San Antonio, Texas, United States and 26 other locations

the safety and tolerability of itacitinib in combination with osimertinib in subjects with locally advanced or metastatic non-small cell lung...

Active, not recruiting
Lung Cancer
Drug: Itacitinib
Drug: Osimertinib

Phase 1, Phase 2

Incyte
Incyte

San Antonio, Texas, United States and 30 other locations

with pemetrexed and platinum chemotherapy in participants with no prior therapy for advanced or metastatic non-squamous non-small cell lung ...

Active, not recruiting
Metastatic Non Small Cell Lung Cancer
Drug: Pembrolizumab
Drug: Carboplatin

Phase 3

Daiichi Sankyo
Daiichi Sankyo

San Antonio, Texas, United States and 256 other locations

Non-Squamous Non-Small Cell Lung Cancer (NSCLC) remains a leading cause of cancer mortality worldwide, with poor survival ...

Active, not recruiting
Non-Small Cell Lung Cancer
Drug: Carboplatin
Drug: Livmoniplimab

Phase 2, Phase 3

AbbVie
AbbVie

San Antonio, Texas, United States and 61 other locations

is to evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of BL-M14D1 in Subjects with locally Advanced or Metastatic Small Cell Lung...

Enrolling
Small-cell Lung Cancer
Neuroendocrine Cancer
Drug: BL-M14D1

Phase 1

Systimmune
Systimmune

San Antonio, Texas, United States and 15 other locations

for the treatment of locally advanced or metastatic non-small cell lung cancer. Some lung cancers are due to muta...

Active, not recruiting
Non-Small Cell Lung Cancer
Drug: Pemetrexed/Carboplatin
Drug: Pemetrexed/Cisplatin

Phase 3

AstraZeneca
AstraZeneca

San Antonio, Texas, United States and 152 other locations

A Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer after failur...

Enrolling
Non-Small Cell Lung Cancer
Drug: Pemetrexed
Drug: Carboplatin

Phase 2, Phase 3

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

San Antonio, Texas, United States and 183 other locations

of this study is to evaluate the efficacy of Pumitamig versus Pembrolizumab in participants with previously untreated advanced Non-Small Cell Lung...

Begins enrollment in 2 months
Non-Small Cell Lung Cancer (NSCLC)
Drug: Pumitamig
Drug: Pembrolizumab

Phase 3

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

San Antonio, Texas, United States and 249 other locations

This Phase 1/2, open-label, multicenter study is conducted in patients with previously treated selected solid tumors, including non-small ce ...

Enrolling
L-MYC and N-MYC Amplified Solid Tumors
Prostate Cancer
Drug: Oral MRT-2359

Phase 1, Phase 2

Monte Rosa Therapeutics

San Antonio, Texas, United States of America and 21 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems